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ABSTRACT 27 
 Gastroenteritis is a clinical illness of humans and other animals characterized by vomiting and 28 
diarrhea, caused by a variety of pathogens including viruses. An increasing number of viral species 29 
have been associated with gastroenteritis or have been found in stool samples as new molecular tools 30 
are developed. In this work, a DNA microarray capable in theory of parallel detection of more than 100 31 
viral species was developed and tested. Initial validation was done with 10 different virus species and 32 
an additional 5 species were validated using clinical samples. Detection limits of 1x10
3
 virus particles 33 
of human adenovirus C (HAdV), human astrovirus (HAstV) and group A rotavirus  (RV-A) were 34 
established. Furthermore, when exogenous RNA was added, the limit for RV-A detection decreased in 35 
one log. In a small group of clinical samples from children with gastroenteritis (n = 76), the microarray 36 
detected at least one viral species in 92% of the samples. Single infection was identified in 63 samples 37 
(83%) and more than one virus was identified in 7 samples (9%). The most abundant virus species were 38 
RV-A (58%), followed by anellovirus (15.8%), HAstV (6.6%), HAdV (5.3%), Norwalk virus (6.6%), 39 
human enterovirus (HEV; 9.2%), human parechovirus (1.3%), Sapporo virus (1.3%) and human 40 
bocavirus (1.3%). To further test the specificity and sensitivity of the microarray, the results were 41 
verified by RT-PCR detection of 5 gastrointestinal viruses. The RT- PCR assay detected a virus in 59 42 
samples (78%). The microarray showed good performance for detection of RV-A, HAstV and 43 
calicivirus, while the sensitivity for HAdV and HEV was low. Furthermore some discrepancies in 44 
detection of mixed infections were observed, and were addressed by RT-qPCR of the viruses involved. 45 
It was observed that differences in the amount of genetic material favored the detection of the most 46 
abundant virus. The microarray described in this work should help to understand the etiology of 47 
gastroenteritis in humans and animals. 48 
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 49 
INTRODUCTION 50 
Gastroenteritis stands among the five principal causes of mortality by disease and morbidity at 51 
all ages worldwide. The most affected population is children under 5 years of age, where it accounts for 52 
the second cause of post-neonatal death with approximately 2.6 millions deceased per year [1]. 53 
Although the majority of deaths occur in developing countries, diarrheal disease is among the most 54 
common causes of illness worldwide, with approximately 4,620 millions episodes annually [1]. Besides 55 
humans, all vertebrate species suffer from enteric diseases. Infections in farm animals can lead to big 56 
economical losses, while household pets, like dogs and cats, are also affected. On the other hand, wild 57 
animals, like deer, monkeys, bats, foxes, wolves, and boars, among others, can act as potential 58 
reservoirs for pathogens [2]. Gastrointestinal (GI) infections are caused by a variety of pathogens 59 
including parasites, bacteria and viruses. The characterization of pathogens causing GI infections of 60 
viral etiology have led to the establishment of a main group of pathogens [rotavirus A (RV-A), 61 
Norwalk virus (NV), human astrovirus (HAstV), and human adenovirus F (HAdV-F)] [3] for which 62 
specific diagnostic tests were developed [4]. Tests for secondary or rare virus are available but usually 63 
restricted to experimental use. Routine diagnostic methods for viral gastroenteritis are nowadays based 64 
on the detection of virus components by immunoassays or by molecular methods [5,6,7,8], with the 65 
majority of these tests designed to evaluate only a single pathogen at a time.  66 
The use of two or more specific primer sets (multiplexing) in polymerase chain reaction (PCR) 67 
allows the amplification of several targets in one test. Although multiplex tests are available for diverse 68 
viruses [9,10,11,12,13], facilitating rapid and sensitive detection of the main GI agents, these assays are 69 
still limited in number of viruses detected, and the results can be affected by mutations at primer 70 
binding sites. On the other hand, DNA microarrays represent an alternative to detect hundreds to 71 
thousands of potential pathogens in a single assay. Microarray detection is based on solid phase 72 
hybridization, in which specific probes are deposited on a surface and react with a mixture of labeled 73 
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nucleic acids. So far, different microarrays have been developed to detect causative infectious agents 74 
associated with a number of diseases: respiratory [14,15,16], hemorrhagic [17], blood borne [18,19], 75 
and central nervous system syndromes [20]. Other broad microarrays have been developed for virus 76 
discovery [21], however, diagnostic microarray specific for viruses found in GI tract is missing. Given 77 
the recent rise in the number of new viral species [22,23,24,25,26], diagnostic DNA microarrays 78 
represent the possibility to test their clinical importance and impact in human and animal health.  79 
In this work, the development and validation of a DNA microarray designed to detect in 80 
principle more than 100 viral species associated with GI tract in vertebrates is presented. This 81 
microarray was successfully used to identify viruses in a small set of gastroenteritis clinical samples. 82 
 83 
MATERIALS AND METHODS 84 
 85 
Cells, viruses, and clinical samples 86 
Viruses were either present in our laboratory or kindly provided by different partner laboratories 87 
(Table 1). Clinical samples from children presenting gastroenteritis during the winter season 2004-2005 88 
were obtained in Monterrey, Mexico, with the written consent of parent or guardian. Analysis of human 89 
clinical samples was approved by the Bioethics Committee of the Instituto de Biotecnologia. The initial 90 
screening of samples for RV-A was performed in Monterrey by silver staining of RV-A segmented 91 
double-stranded RNAs separated by SDS-PAGE electrophoresis. No previous screening for bacterial or 92 
parasitic agents was performed on group of samples. Triple layered particles of RV-A strain RRV were 93 
purified by cesium chloride density gradient as described previously [27].  94 
  95 
Microarray probe design 96 
All virus species that have been either associated with gastroenteritis or found in the 97 
gastrointestinal tract were identified by an extensive review of published literature, and selected to be 98 
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included in microarray. All available full-length genomes or complete gene sequences of the selected 99 
virus species were obtained from GenBank (up to February 2009) and the proper databases were 100 
created. For each virus species, sequence redundancy was eliminated according to a sequence similarity 101 
with cutoff values 95-99% using CD-HIT software [28]. One sequence for each species was selected as 102 
source for probes production and was processed as described [29].  Specifically, sequences were 103 
consecutively split into 70-mers with a shifting window of 3 nucleotides, with each 70-mer 104 
corresponding a potential probe. The 70-mer length probes have sufficient size to allow for stringent 105 
hybridization conditions while allowing for certain degree of mismatches, but are small enough to 106 
maintain species specificity [30,31,32]. Target probes were selected to be included in the microarray by 107 
analysis of BLAST results and calculation of hybridization thermodynamics (G) calculated by the 108 
nearest-neighbor method [33]. To be considered good candidates for microarray, the G was required 109 
to be at least -70 kcal/mol for homologous sequence and higher than -40 kcal/mol for heterologous 110 
sequences. A minimum of 6 non-overlapping probes from conserved regions in virus genomes were 111 
selected for each virus, and each available genome sequence in target database for given species was 112 
recognized by at least two probes. When necessary, due to variability within a species, two or more 113 
source sequences were chosen and each single sequence was processed as described above.  114 
 115 
Microarray probes in-silico analysis 116 
Hybridization thermodynamics of RV-A selected probes was evaluated in-silico with VP1, VP2 and 117 
NSP5 segments of RV-A strains representing all full-genome  G and P genotypes available. 118 
Hybridization ΔG (kcal/mol) between probe and target was calculated by nearest-neighbor method. 119 
Best probe-target ΔG was plotted in heatmap using R. Detection of a target is considered with ΔG < -120 
50 kcal/mol.   121 
 122 
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Microarray production  123 
 Selected 70-mer probes were synthesized by Illumina Oligator (Illumina Inc, CA, USA). 124 
Oligonucleotides were resuspended to 400 pmol in 3X SSC buffer (0.45 M NaCl, 45 mM sodium 125 
citrate pH 7.0), and spotted onto epoxide-coated glass slides in the Microarray Facility of the Prostate 126 
Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada. Each spot contained one 127 
specific probe to detect one virus species, and 4 pmol of spike70 (a 70-mer without biological 128 
complementary known sequence) [34] used to precisely identify probe spot locations on the 129 
microarray. Slides were maintained in humidity-free chamber until their use. 130 
 131 
Nucleic acid extraction, amplification and labeling 132 
Genetic material from virus lysates (cell culture supernatants from reference strains) was 133 
extracted by PureLink Viral RNA/DNA kit according to the manufacturer’s instructions (Invitrogen, 134 
USA). For clinical samples, Norwalk and Sapporo virus positive controls, 100 g of stool was added to 135 
conical screw cap tubes containing 100 mg of 150-212 m glass beads (Sigma, USA), chloroform (100 136 
l) and PBS up to 1ml. Samples were homogenized in a bead beater (Biospec Products, USA). After 10 137 
min centrifugation at 2000 x g supernatants were recovered and filtered in Spin-X 22 m pore filters 138 
(Costar, NY) at 5000 x g during 10-20 min. Filtered samples were treated with Turbo DNAse  139 
(Ambion, USA) and RNAse (Sigma, USA) for 30 min at 37°C and immediately chilled on ice. Nucleic 140 
acids were then extracted from 200 l using PureLink Viral RNA/DNA kit according to manufacturer’s 141 
instructions (Invitrogen, USA). Nucleic acids from virus lysates or clinical samples were eluted in 142 
nuclease-free water, aliquoted, quantified in NanoDrop ND-1000 (NanoDrop Technologies, DE) and 143 
stored at -70°C until further use. 144 
Sample processing and random-amplification of nucleic acids was performed essentially as 145 
described previously [21,35,36].  Briefly, reverse transcription was done using SuperScript III Reverse 146 
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Transcriptase (Invitrogen, USA) and primer-A (5'-GTTTCCCAGTAGGTCTCN9-3'). The 147 
complementary DNA (cDNA) strand was generated by two rounds of synthesis with Sequenase 2.0 148 
(USB, USA). The obtained cDNA was then amplified with KlenTaq polymerase (Sigma, USA) or Taq 149 
Polymerase (New England Biolabs, USA) using the primer-B (5'-GTTTCCCAGTAGGTCTC-3') by 30 150 
cycles of the following program: 30 sec at 94°C, 1 min at 50°C, 1 min at 72°C. As a last step, 151 
nucleotide-analogue aminoallyl-dUTP (TriLink, USA) in a 7:3 ratio with dTTP was incorporated 152 
during an additional 20 cycles of PCR using the same conditions described above and 5 l of product 153 
from the previous PCR as starting material. The amplified products were purified with DNA Clean & 154 
Concentrator-5 kit (Zymo Research, USA).  Coupling reactions of sample DNA with Cy3 and probe-70 155 
(70-mer complementary to spike-70) with Cy5 dyes (GE HealthCare, USA) were done as described 156 
elsewhere [31]. Fluorophore-labeled DNA was purified by the Zymo DNA Clean & Concentrator-5 kit 157 
and label incorporation was quantified by NanoDrop. 158 
 159 
Slides preparation, hybridization and scanning 160 
Microarray slides were treated just before their use with an ethanolamine wash solution (50 mM 161 
ethanolamine, 0.1 % SDS, 0.1M Tris pH 9) for 15 min at 50°C, followed by two washes in distilled 162 
water, and they were then dried by centrifugation for 5 min at 500 rpm. Processed slides were loaded 163 
with 30 l of a combination of Cy3 and Cy5 labeled DNA in 3xSSC buffer, and the hybridization was 164 
left to proceed in a sealed chamber submerged in a water bath at 65°C for 8-12 h. After incubation the 165 
slides were washed consecutively in the following solutions: 2xSSC (65°C), 2xSSC, 1xSSC, 0.2xSSC 166 
and dried for 5 min at 500 rpm. Hybridization images were acquired with an Axon GenePix 4000B 167 
scanner (Molecular Devices, USA) synchronized with GenePix Pro 6.0 software to detect and measure 168 
spot intensities. 169 
 170 
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Data Analysis 171 
Hybridization spot intensities were first filtered by the following spot-quality control 172 
parameters: spot size and shape (denoted as good/bad/absent), channel 532 foreground (F532) signal 173 
saturation (% F532 saturated < 5), and F532 signal proportion over channel 532 background (B532) 174 
signal [(% > B532 + 2 standard deviations) > 50%]. Spots showing good quality were used to generate 175 
microarray level background values. Normalization of intensity values was done with the formula: 176 
(F532i/F532m)-(B532i-B5532m) where F532i and B532i stands for foreground and background signal 177 
of spot  “i” respectively, and F532m and B532m stands for the sum of all foreground or background 178 
spots respectively.   179 
The statistical significance of probe intensities in the reference samples was obtained by the 180 
rank products algorithm [37] using a minimum of three technical replicates. Rank values from negative 181 
control samples were recorded and used to generate a 'spot rank value' included in subsequent spot-182 
quality analysis. For clinical samples, z-score transformed intensities and their p-values were analyzed 183 
with fdr tool package [38] in R [39]. Positive virus species were defined as having at least two probes 184 
with p-values < 0.05 and a false discovery rate < 0.01.  185 
 186 
 187 
Limits of detection assays 188 
 In order to determine the amount of virus particles detectable by the microarray, three reference 189 
viruses with different genome types were assayed: dsRNA RV-A, positive single stranded RNA 190 
(ssRNA+) HAstV and double stranded DNA (dsDNA) HadV-C. RNA was extracted from purified RV-191 
A strain RRV, and MA104 cells. The RV-A genome molecular mass was calculated according to the 192 
following formula: [genome length (bp) x 325] / 6.022x10
23  
[40]. Decreasing dilutions of RV-A RNA 193 
corresponding from 1x10
8
 to 10 particles; were analyzed alone or mixed with an excess of MA104 cells 194 
RNA (50 ng). Similarly, decreasing dilutions of focus forming units titrated cell lysates of HAstV or 195 
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HAdV-C, corresponding from 1x10
7
 to 100 virus particles were extracted, amplified, labeled, and 196 
processed using the full microarray protocol as described above.  197 
 198 
Conventional diagnostic or confirmatory RT-PCR 199 
 Nucleic acids extracted from clinical samples were used to perform diagnostic RT-PCR using 200 
Qiagen's One-Step RT-PCR kit (Qiagen, USA) or Super Script III One-step RT-PCR with Platinum 201 
Taq (Invitrogen, USA). For confirmatory RT-PCR, cDNA was generated with SuperScript III Reverse 202 
Transcriptase (Invitrogen, USA), and Taq Polymerase (New England Biolabs) was used for PCR 203 
reactions following the manufacturer’s instructions. Oligonucleotide primers used in diagnostic or 204 
confirmatory RT-PCR are listed in Supplementary Table 1.  PCR reactions for RV-A detection 205 
included a 5 min boiling followed by immediate ice-chilling step just before RT-PCR. Amplification 206 
conditions for RV-A , HAstV and calicivirus (CV) were: 30 min at 50°C, 15 min at 95°C; 40 cycles of 207 
30 sec at 95°C, 30 sec at 50°C, 1 min at 72°C, with final extension of 5 min at 72°C. RT-PCR 208 
conditions for human adenovirus (HAdV) were: 30 min at 50°C, 15 min at 95°C; 40 cycles of 30 sec at 209 
95°C, 30 sec at 55°C, 1 min at 72°C, with final extension for 5 min at 72°C. Human enterovirus (HEV) 210 
amplification program was: 30 min at 50°C, 15 min at 95°C; 40 cycles of 30 sec at 95°C, 30 sec at 211 
50°C, 30 sec at 72°C, with final extension for 5 min at 72°C.  Human parechovirus (HPeV) 212 
amplification was: 30 min at 50°C, 15 min at 95°C; 35 cycles of 1 min at 95°C, 1 min at 48°C, 1 min at 213 
72°C, with final extension for 5 min at 72°C. Anellovirus (TTV) confirmation was performed as semi-214 
nested PCR, conditions for the first round were: 2 min at 94°C; 35 cycles of 30 sec at 94°C, 30 sec at 215 
55°C, 30 sec at 72 °C, with final extension for 5 min at 72°C. The second round used the same program 216 
but only with 30 cycles. Human bocavirus (HBoV) was detected by Seeplex RV15 OneStep ACE 217 
Detection (Seegene, USA). PCR products were visualized in 2.0% agarose gels except for HEV, which 218 
required 3.5% gels due to small amplicon size. 219 
 220 
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Semi quantitative RT-PCR/PCR detection of viruses 221 
 One-step real-time RT-PCR and real-time PCR were performed using primers targeting 222 
conserved genomic regions (Supplementary Table 1). RV-A detection required previous sample boiling 223 
for 5 minutes and immediate ice-chill. For the RNA viruses (RV-A, HAstV, NV and HEV), detection 224 
was performed as a two-step process. First, 3 l of RNA (5 ng) were reverse transcribed with 0.125 l  225 
(50 U/l)_SuperScript III Reverse Transcriptase (Invitrogen, USA), 0.25 l of RNAse inhibitor (20 226 
U/l), 12.5 l of SYBR Green Master Mix 2X (Applied Biosystems, USA), 1 l of the primer and 227 
DEPC treated water in a 24 l final volume. Samples were incubated for 30 min at 48°C followed by 228 
enzyme inactivation for 10 min at 90 °C. In the second step 1 l of second primer was added and PCR 229 
conditions were carried out as follows: HAstV and RV-A amplification program consisted of 10 min at 230 
95°C, and 40 cycles of 15 sec at 95°C and 1 min at 60°C. NV amplification program was 5 min at 231 
95°C, 45 cycles of 10 sec at 95°C, 20 sec at 48°C, 45 sec at 60°C. HEV program was 10 min at 95°C, 232 
45 cycles of 20 sec at 95°C, 20 sec at 55°C, 1 min at 72°C and final extension of 5 min at 72°C. In the 233 
case of HEV, both specific primers were added before PCR, since the RT step was performed using 234 
random hexamers. HAdV amplification reactions consisted in 3 l (5 ng) of DNA, 12.5 l of SYBR 235 
Green Master Mix 2X and 1l of each corresponding primer in a 25 l volume reaction. Conditions 236 
were 95°C for 8 min, 45 cycles of 30 sec at 95°C, 20 sec at 55°C, 20 sec at 72°C, final extension of 5 237 
min at 72°C. Amplifications were carried out in an ABI Prism 7500 Sequence Detector System 238 
(Applied Biosystems). Dissociation curves were evaluated for non-specific products. Ct values 239 
corresponding to detection of specific virus sequences were obtained from triplicates of selected 240 
samples presenting co-infections and compared for the viruses detected. PCR primer sets for detection 241 
of CV, HAdV and HEV were designed to recognize the target at the genus level [5,6,41].   242 
 243 
RESULTS 244 
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Selection of viruses related to gastrointestinal infections 245 
An advantage of the microarray technology is the capacity to test hundreds, and even thousands 246 
of targets in a single assay. The main goal of this study was to develop an assay for detection of all 247 
viruses that have been found in stool samples from vertebrate, associated or not with gastroenteritis, 248 
what should facilitate clinical and epidemiological studies in humans and animals. A deep search of the 249 
scientific literature available in public databases resulted in a list of 128 viral species of viruses 250 
reported to be present in the gastrointestinal tract, representing 55 genera that belonged to 17 viral 251 
families (Supplementary Table 2).  The list of virus species includes the well known human 252 
gastroenteritis viruses (calicivirus group, rotaviruses, human astroviruses, enteric adenoviruses), 253 
together with some recently described human viruses [human adenovirus G [23], human bocavirus 254 
[42], cosavirus [24], Saffold virus [43] and salivirus A [25,44]]. Classical, non-human gastrointestinal 255 
viruses (coronavirus, circovirus, and pestiviruses), and other new discovered viral agents (at the time of 256 
the microarray design) from different animal species, such as animal anelloviruses [45,46], bat 257 
astroviruses [47], and bovine kobuviruses [48], whose participation as pathogens is not well 258 
understood, are also  included in the microarray. Thus, the virus species of interest comprehended a 259 
variety of viruses with different characteristics, such as RNA and DNA genomes, enveloped/non-260 
enveloped virions, segmented or non-segmented genomes, single- or double-stranded genomes. All 261 
available complete gene or genome sequences were retrieved from a public database (GenBank) and 262 
were organized in a taxonomic hierarchical database following the ICTV classification at the date the 263 
microarray probes were design (ICTV, 2009) or, for novel species, as suggested by the discoverer. 264 
 265 
Probe selection and microarray validation 266 
A set of 1,256 70-mer microarray probes were selected from conserved regions and designed to 267 
identify 128 viral species associated with the GI tract, with at least 6 probes designed for each viral 268 
species and at least 2 probes corresponding to each sequenced viral genomes. To maintain stringent 269 
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experimental conditions (hybridization at 65
o
C) while allowing certain number of sequence variability, 270 
the probes were designed as 70-mers. The highest number of probes covered RV-A (42 probes), 271 
alphacoronavirus (28 probes), and mammalian orthoreovirus (25 probes) (Supplementary Tables 2 and 272 
3). For some viruses, the design of a complete set of 6 oligonucleotides was not possible due to the lack 273 
of enough complete sequences, nevertheless available probes were included for each viral species. 274 
Reference strains for 10 viral species were available for probe validation. These species 275 
represent 6 viral families and include 4 main human pathogens (HAstV, NV, SV, RV-A), other human 276 
viruses (mammalian orthoreovirus , HAdV-C, dengue virus 4), and three non-human viruses (feline 277 
calicivirus, bovine viral diarrhea virus 1, and bovine parainfluenza virus 3) (Table 1). All reference 278 
strains tested were detected as expected, including four different RV-A strains (human strain Wa, 279 
simian strain RRV, porcine virus TFR-41, and bovine strain UK) and two different mammalian 280 
orthoreovirus strains (T1L and T3D) (Table 1). To test in-silico capacity of probes to recognize 281 
different and variable strains, 42 probes specific for rotavirus were analyzed with panel of all available 282 
G and P genotypes  (Supplementary Figure 1). The only genotype that the microarray would not 283 
probably detect was G22P[35] belonging to a turkey rotavirus strain.   284 
 285 
Sensitivity and specificity of the assay 286 
To determine the sensitivity limits of the DNA microarray, the virus genetic material was 287 
extracted from lysates of HAstV- or HAdV-C-infected cells or from CsCl-purified simian strain RRV 288 
particles. In a series of cell lysate dilutions (corresponding from 10
2
 to 10
7 
viral particles), the 289 
microarray was able to detect as low as 10
3
 HAdV-C or HAstV virus particles. Similarly, RV-A RNA 290 
(corresponding from 10 to 10
8
 viral particles) was amplified before or after addition of a constant 291 
amount of cellular RNA (50 ng). In the absence of cellular RNA the detection limit of viral RNA was 292 
10
3
 genome copies, however, when the complexity of the sample was augmented by adding cellular 293 
RNA, the detection limit was one logarithm lower, detecting 10
4 
genome copies.  294 
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 To evaluate the probe specificity, a rank products algorithm [37] was applied to the results 295 
obtained from technical replicates of reference viruses and mock-infected cell controls (MA104 cells, 296 
A549 cells, and C6/36 cells). Based on the false discovery rate test (FDR) included in the software, 16 297 
probes were identified as presenting nonspecific behavior (marked with * in Supplementary Table 3). 298 
When analyzed, these nonspecific probes did not show any common feature, although some presented 299 
high GC content (>70%).  In the following experiments the results obtained with these probes were 300 
excluded from analysis.  301 
 302 
Analysis of clinical samples 303 
To further test the capacity of the microarray to detect viruses, 76 samples from children under 304 
5 years of age, collected during the winter season 2004-2005 in Monterrey, Mexico, was analyzed. The 305 
collection of samples was originally screened for RV-A by polyacrylamide gel electrophoresis (SDS-306 
PAGE), and stored at -70°C. Using the microarray developed in this study, a viral agent was detected 307 
in 70 out of 76 (92 %) samples tested; a single virus was found in 63 (83%) samples, while two or more 308 
viral species were detected in 7 (9%) samples (Fig. 1). Among the viruses detected, the most common 309 
was RV-A (44 samples), followed by TTV (12 positives), HEV  (7), caliciviruses (6 positives – 5 NV 310 
and 1 SV), HAstV (5), HAdV (4 positive samples- 3 HAdV-F and 1 HAdV-A), HPeV (2) and one 311 
HBoV (Fig. 1). It is important to mention that only 6 (8%) samples remained negative after microarray 312 
detection, and that not all viruses found are known to be pathogenic.  As mentioned above, after 313 
collection all samples were screened for the presence of RV-A by SDS-PAGE. Additionally, as 314 
described below, all samples tested with the microarray were tested for selected viruses by diagnostic 315 
RT-PCR, including RV-A. In thirty-four samples RV-A was identified by the three methods tested; 5 316 
additional samples were found positive by microarray and RT-PCR tests (Fig. 2). Another 8 were 317 
found positive either by microarray (n=5) or by RT-PCR (n=3) (Fig 2). Notably, the 3 samples that 318 
were only positive for RV-A by RT-PCR were found in mixed-infection samples. 319 
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To compare the results of the microarray with those of a routine diagnostic method for viral 320 
gastroenteritis, RT-PCR detection for a panel of 5 viruses [RV-A, HAstV, HAdV, CV (NV and SV) 321 
and HEV] was performed in all clinical samples. It is important to point out that the primer sets for 322 
HAdV, CV, and HEV are designed to recognize its target at the genus level [5,6,41].   323 
 The RT-PCR panel detected at least one virus in 59 samples (78%; Fig. 1B), a lower detection 324 
rate when compared to the DNA microarray when analyzing only these 5 viruses (n= 65, 85%). At the 325 
individual virus level, the RT-PCR panel confirmed the microarray results in all HAdV-positive 326 
samples (1 HAdV-A and 3 HAdV-F), having a positive predictive value (PPV) of 100%, all CV (5 NV 327 
and 1 SV) (PPV, 100%) , and 39 of 44 RV-A positive samples (PPV, 89%), while PPVs were lower for  328 
HAstV, with 3 of 5 positive samples identified (PPV 60%),  and  5 of 7 HEV positive samples 329 
identified by microarray (PPV 71%)  (Fig. 3).  330 
 331 
Detection of viruses in mixed infections 332 
 The RT-PCR screening resulted in the identification of 16 mixed infections (MI), while the 333 
microarray identified only 7 MI (Fig. 1). The microarray detected up to 4 different viruses within one 334 
sample, with TTV found in all MI samples. The following viral combinations were found by 335 
microarray: HEV B/TTV (3 samples); and one sample of each NV/TTV; HEV-B/HAstV/TTV; RV-336 
A/HPeV/TTV; and SV/HEV-B/HPeV/TTV (Fig. 1). Of interest, human parechovirus and Sapporo 337 
virus were detected only in co-infection. The MI combinations observed in RT-PCR were: RV-338 
A/HAdV (8), RV-A/HEV (5), HAstV/HEV (1), RV-A/CV (1), and one triple infection 339 
HAdV/CV/HEV (Fig. 1B).  Examining these 16 samples, we observed that RV-A was the only virus 340 
identified by microarray in all samples with RV-A/HAdV co-infection (n= 8), and in 4 out of 5 RV-341 
A/HEV samples, while HAstV was the only virus identified in sample with HAstV/HEV co-infection 342 
(Table 2). In one sample NV was identified as the sole species by microarray, while RT-PCR results 343 
showed CV/HAdV/HEV triple co-infection (Table 2). Thus, in all of these 16 samples a single virus 344 
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was identified by the microarray, while at least two viral species were detected by RT-PCR.  345 
One possible explanation for the discrepancies in the identification of mixed infections using 346 
microarrays and RT-PCR could be the variability in the relative amount of each virus genetic material 347 
in clinical samples, as it has been observed that individuals infected with some viruses, for example 348 
RV-A and NV, can shed large amount of viral particles in the acute stage of infection [49,50,51]. To 349 
explore this possibility, the amount of viral genetic material in selected samples with mixed infection 350 
was quantified by real-time RT-PCR. The use of equal quantities of starting material allowed us to 351 
compare directly the amplification Ct's of two viruses within a sample.  The results showed that the 352 
single virus detected by microarray had, in most cases, a lower Ct value as compared to the second 353 
virus detected by qRT-PCR, with the only exception being the combination of RV-A/HEV, where RV-354 
A was the only virus identified by microarray despite the fact that HEV had lower Ct values (Table 2). 355 
This indicates that MIs presenting large differences in the amount of the genetic material of the viral 356 
agents involved are prone to result in single virus detection by the microarray, generally, the one 357 
present more abundantly. 358 
As consequence, when comparing the sensitivity and specificity of he microarray, as compared 359 
with the panel of individual diagnostic RT-PCR, the most prevalent or most frequently found viruses in 360 
single infections, such as RV-A, HAstV, and CV, showed good sensitivity and specificity (from 85-361 
100%), while the sensitivity for viruses like HAdV and HEV was low, ranging from 30 to 42%, being 362 
clearly affected by other viruses present in the sample (Fig. 3, Table 2). For example, 4 samples that 363 
presented only HAdV were found positive by both microarray and RT-PCR, while in the remaining 9 364 
samples, which presented HAdV co-infection with RV-A (8 samples) and one with CV, only the 365 
second virus was identified by microarray  (Table 2). It should be pointed out that most of these 366 
samples contained a low level of HAdV genetic material, with Ct values close to non-template control 367 
value (Ct 44.5) (Table 2). 368 
 369 
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Detection of not common GI viruses 370 
Of note, the microarray found 3 viruses that usually are not evaluated in gastroenteritis samples. 371 
Two samples presented HPeV, both in co-infection (one with RV-A/ TTV, another with SV/ HEV B/ 372 
TTV). An additional sample containing HBoV was identified (RV-A was identified by RT-PCR in this 373 
sample), and 12 samples presented TTV, 5 samples as single infection and 7 in co-infection with other 374 
viruses. As reference samples for these viruses were not available, confirmation RT-PCR coupled with 375 
capillary sequencing were performed, and the viruses detected by the microarray were confirmed in all 376 
these samples (results not shown). Fact that TTV single virus positive samples were found is not an 377 
indicator of causativeness. 378 
 379 
DISCUSSION 380 
Current routine viral testing is designed to detect only the most prevalent viruses, leaving 381 
frequently a 30-50% of cases without an agent identified [52]. In recent years, advances in molecular 382 
biology and the implementation of next generation sequencing has allowed the identification of several 383 
new viruses in intestinal samples [53,54,55,56,57].  The role of most of these viruses in diarrheal 384 
disease remains unclear (Aichi virus, anellovirus, human bocavirus, human parechovirus, human 385 
picobirnavirus, and some enteroviruses, among others) raising the need to study in detail their 386 
epidemiology. In order to gather information on GI virus diversity, proper tools are required for their 387 
monitoring. In this work a comprehensive and sensitive DNA microarray was developed and tested, 388 
which allows in principle the parallel detection of more than 100 gastrointestinal associated virus 389 
species. 390 
Implementation of the microarray for detection of viruses is not an easy task. Design of probes 391 
and experimental conditions are two important parameters to consider. Resequencing microarrays 392 
permit identification of mutations but require high numbers of probes for a single agent, increasing its 393 
cost [58]. Arrays for sub-typing use less and shorter probes but are often designed for only one viral 394 
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species [59,60,61,62,63]. Microarrays used for virus discovery have proven very useful when usual 395 
suspects are discarded or in rare disease cases, but identification is not clear and require complex 396 
analysis [34].  397 
Several DNA microarrays have been previously reported for identification of the main known 398 
gastrointestinal pathogenic viruses [59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75], however, 399 
they were mostly oriented to the identification or sub-typification of one viral species, and none had 400 
specifically addressed the list of viruses that can be found in stool samples.  401 
The microarray platform described in this work has been validated with 14 reference viral 402 
strains, representing 10 different virus species. Importantly, 5 other viral species were identified using 403 
the microarray when analyzing clinical samples: HAdV-F, HAdV-A, HPeV , HBoV, and several TTV. 404 
The capacity of the microarray to identify correctly viruses whose probes were not validated in this 405 
work with cultured reference strains confirms that the methodology used to design probes is adequate, 406 
and increases the probability that the remaining probes will be also capable to identify their target 407 
viruses, this is additionally supported by in-silico  detection of wide variety of RV-A strains using 408 
probes obtained from conserved genes; however, testing with other reference strains would be 409 
necessary. During the validation experiments some probes were found to react non-specifically with the 410 
amplified labeled DNA, regardless of its origin, in other words, they were found to be ‘sticky’, and 411 
they were excluded from further analysis. No common characteristic was found between these probes 412 
that could account for their non-specific binding behavior.  413 
One of the critical parameters in virus detection is the sensitivity of the assay. There are several 414 
factors that can affect the sensitivity. In the case of a microarray, sample nucleic acids are generally 415 
processed by random primed amplification prior to hybridization, to ensure amplification of a wide 416 
variety of viruses. The product of random-PCR could be lower than that of specific PCR, decreasing 417 
the sensitivity of the assay as all genetic material is amplified, diluting the positive signal [76]. Limit of 418 
detection for three viruses with different genome types (dsDNA, dsRNA and ssRNA+) was established 419 
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in 10
3 
virus particles, suggesting that genome nature does not affect the sensitivity of the assay. 420 
Moreover, testing the sensitivity of the microarray with purified RV-A RNA, we observed that addition 421 
of 50 ng of cellular RNA as a non-specific diluting RNA, decreased the sensitivity of detection ten-422 
fold. To try to solve the sensitivity problem in complex clinical samples, agent-specific primers have 423 
been included in previous reports, together with random primers during amplification of the genetic 424 
material [14,15], with the disadvantage of narrowing the scope of targets for the microarray assay.  425 
We subsequently analyzed a group of clinical samples collected from children with diarrhea. 426 
Initially, the clinical samples were screened by SDS-PAGE, which led to the identification of 34 RV-A 427 
positive samples, while the microarray presented in this work identified 44, suggesting that the 428 
microarray platform has a higher sensitivity than traditional methods. A similar sensitivity was 429 
obtained by RT-PCR, as 42 samples were found RV-A-positive. Even though our results indicate that 430 
the limit of detection of purified virus (1x10
3
 viral particles) is similar to that reached with PCR assays 431 
[8], the microarray had a higher number of positive results when clinical samples were tested, possibly 432 
due to the natural genetic variation in primer binding regions of viruses found in sample viruses.   433 
Although multiplexed assays are being developed, their use in routine testing is not generally 434 
implemented, and most studies use single pathogen tests. When RT-PCR screening for the most 435 
common viruses is performed, the percentage of clinical samples without a virus identified remains 436 
around 30-50% [13,77,78], while the microarray presented in this study detected a virus in 92% of the 437 
samples. This high detection rate could have been influenced by the time of sampling, since winter is a 438 
high season for viral gastroenteritis in the region and no pre selection for pathogens was performed. An 439 
additional advantage of the microarray test as compared to a set of different RT-PCR assays, is the 440 
capacity to identify viruses that are not commonly tested for, like those previously associated with 441 
diarrhea (like HPeV) and those of unclear clinical significance in GI disease (HBoV and TTV). In this 442 
work we found a wide range of circulating not typical viruses among children, similarly as observed in 443 
other studies [79,80] and their continuous surveillance should be considered. To our knowledge, this is 444 
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first report of description of HPeV, HBoV, and TTV in Mexican children.  445 
 As a consequence of the limited number of virus species routinely tested, prevalence of co-446 
infections is a poorly explored issue. Usually, when a panel of up to 5 viruses is used, co-infection rates 447 
between 4-18% are observed, being the most common combination RV-A/NV [2,13,77,81,82,83]. 448 
More recently, wide scope ranging metagenomic studies have shown that mixed infections are more 449 
common than previously thought [4,80], even in healthy individuals [79]. The analysis of the small set 450 
of clinical samples analyzed in this work showed that 30% (23 out of 76) contained more than 1 451 
gastrointestinal virus. The identification of individual viruses in co-infections presented some 452 
discrepancies when comparing the results from microarray and RT-PCR tests. Of seven samples with 453 
mixed infections  identified by the microarray, five were confirmed by RT-PCR, while in  16 mixed 454 
infection identified by RT-PCR, a single virus was identified by the microarray, suggesting that the 455 
microarray may be less sensitive than RT-PCR for detection of mixed infections. To address this 456 
inconsistency, real time RT-PCR was implemented for the principal combinations of viruses that were 457 
missed by the microarray. This platform showed certain advantage for detection of RV-A over HAdV 458 
and HEV, as RV-A was identified even when the HEV  genome was present in larger amounts. HEV 459 
was identified by microarray in samples co-infected with RV-A only when RV-A RNA was present in 460 
low amounts, close to negative control levels (Table 3). Preferential identification of RV-A by the 461 
microarray could be due to the large amount of virus particles excreted during the acute phase of 462 
infection, and by the large number of probes selected (42 oligonucleotides), as compared to 5 and 17 463 
probes for HEV A and HEV C, respectively, and 17 probes for HAdV.  On the other hand, the two 464 
HEV samples positive for microarray that were missed by RT-PCR correspond to mixed infections, 465 
with HAstV/TTV and SV/HpeV/TTV, respectively. Despite several attempts to identify HEV in these 466 
samples by RT-PCR resulted in negative results, thus the possibility of a microarray false positive 467 
result cannot be discarded. 468 
 The number of virus species identified has increased considerably in the last decade with the 469 
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application of emerging genomic technologies such as microarrays and unbiased next-generation 470 
sequencing in studies of fatal or rare cases of disease in humans, wild, and domestic animals 471 
[25,56,84,85,86]. Adequate tools that allow detection of well-known pathogenic viruses while are 472 
capable of detecting the new or rare viruses in a single assay will contribute with useful 473 
epidemiological information about both kinds of viruses. This microarray includes viruses of different 474 
host origin in order to extend the range of use to veterinary studies. The oligonucleotide probes selected 475 
should allow the identification of target viruses despite the sequence variations that will occur in the 476 
following years, however, it will be important to update the microarray design on a regular basis to 477 
maintain the capacity to broadly detect pathogenic viruses and to include newly found viral species.  478 
Parallel detection of gastroenterical viruses beyond the most common viruses should facilitate a 479 
better understanding of virus etiology, as it increases the rate of positive cases, closing the diagnostic 480 
gap, and allows inspection for mixed infections where secondary viral agents could represent an 481 
important factor. Adding data from case control studies and inclusion of other host parameters, as 482 
serological data, will help to provide evidence of virus pathogenicity. Furthermore, adequate and 483 
comprehensive epidemiological studies in wild and domestic animals should be considered. 484 
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 768 
 769 
Figure 1. Prevalence of viruses in clinical samples. A group of 76 clinical samples from children 770 
presenting gastroenteritis was analyzed by the described microarray (A) or by diagnostic RT-PCR for 5 771 
most common gastrointestinal pathogens (B). Samples with co-infections are shown. NEG is for 772 
negative result (no virus identified).  773 
 774 
Figure 2. Identification of rotavirus group A. A group of 76 gastroenteritis samples was analyzed by 775 
three methods for the presence of rotavirus. These included visualization of rotavirus dsRNA on SDS-776 
PAGE gel, RT-PCR, and the microarray designed in this work. The circles represent numbers of 777 
rotavirus positive samples identified by one, two, or three methods used .  778 
 779 
 27 
Figure 3. Microarray diagnostic sensitivity and specificity. A panel of 5 virus groups [rotavirus group 780 
A (RV-A), human astrovirus (HAstV), human adenovirus (HAdV), calicivirus (CV), and enterovirus 781 
(HEV)] was tested by RT-PCR in all 76 samples. Results were compared to those obtained by 782 
microarray analysis. The sensitivity, specificity, positive predictive value (PPV) and negative 783 
predictive value (NPV) of microarray (array), as compared to RT-PCR (PCR), for detection of 784 
particular pathogens are shown. 785 
 786 
Supplementary Figure 1. In-silico hybridization of available RV-A G and P genotypes. Hybridization 787 
thermodynamic values (ΔG) were calculated for all 42 RV-A probes (labeled on the bottom) interacting 788 
“in-silico” with RV-A isolates representing different G and P genotype combinations. RV-A probes 789 
belong to VP1, VP2 and NSP5 segments (marked on top). G and P genotype combinations (marked on 790 
left) belong to RV-A strains isolated from different hosts (human, cow, dog, cat, simian, rhesus, pig, 791 
horse, goat, lamb, sheep, antelope, guanaco, mouse, rabbit, pigeon, chicken, turkey), marked on right, 792 
for whom complete genomes are available. From 27 G genotypes, complete genomes for 21 are 793 
available, while from 35 P genotypes only 23 are represented. Successful detection by RV-A probes is 794 
considered when ΔG value is below -50 (shades of blue). RV-A reference strains (Wa, UK, RRV) used 795 
for validation are depicted as G1P[8]-human, G6P[5]-cow and G3P[3]-simian respectively. 796 
 797 
 798 
 799 



Table 1. Reference virus species used in microarray validation 
 
Family 
 
Genus 
 
Species 
 
Straina 
probes 
positive/totalb 
Astroviridae Mammastrovirus Human astrovirus Yuc8 4/4 
Adenoviridae Mastadenovirus Human adenovirus C Adv5 10/13 
Caliciviridae Vesivirus Feline Calicivirus F9 14/22 
 Norovirus Norwalk virusc - 8/12 
 Sapovirus Sapporo virusc - 5/14 
Flaviviridae Pestivirus Bovine Viral Diarrhea Virus 1 NADL 6/6 
 Flavivirus Dengue virus 4 - 9/9 
Paramyxoviridae Respirovirus Bovine parainfluenza virus 3 SF-4 9/9 
Reoviridae Rotavirus Rotavirus A RRV 22/42 
   TFR-41 14/42 
   UK 19/42 
   Wa 21/42 
 Orthoreovirus Mammalian Orthoreovirus T1L 11/25 
   T3D 19/25 
a Reference strains were provided by Dr. Ramon Gonzalez, FC-UAEM, (Human adenovirus C);  Dra. Lorena 
Gutierrez, CINVESTAV-IPN, (Feline Calicivirus, Norwalk virus, Sapporo virus);  Dra. Rosa E. Sarmiento, 
FMVZ-UNAM (Bovine Viral Diarrhea Virus 1, Bovine parainfluenza virus 3);  Dra. Rosa Ma. Del Angel, 
CINVESTAV-IPN (Dengue virus 4); M.D. Terrence S. Dermody, Vanderbilt University School of Medicine 
(Mammalian orthoreovirus)  
b number of oligonucleotide probes which recognized virus/  total number of oligonucleotide probes designed to 
bind viral species 
c clinical reference samples 
 
 
Table 2. Ct values of viral nucleic acid quantification in samples with co-infection 
 
RT-PCRa Microarrayb RV-Ac HAdV HEV NVd HAstV 
RV-Ae RV-A 21.9f     
HAdV HAdV  14.7    
HEV HEV   23.8   
*NV NV    19.6  
HAstV HAstV     14.8 
RV-A/HAdV RV-A 20.5g 37.6    
RV-A/HAdV RV-A 22.5 28.4    
RV-A/HAdV RV-A 28.2 41.3    
RV-A/HAdV RV-A 28.6 44.5    
RV-A/HAdV RV-A 29.1 43.8    
RV-A/HAdV RV-A 29.2 43.4    
RV-A/HAdV RV-A 30.4 30.6    
RV-A/HEV RV-A 29.2  25.4   
RV-A/HEV RV-A 29.2  27.3   
RV-A/HEV RV-A 29.6  28.5   
RV-A/HEV RV-A 30.8  27.8   
RV-A/HEV HEV 38.4  28   
RV-A/NV NV 30.1   23.6  
HAstV/HEV HAstV   28  23.2 
NV/HEV/HAdV NV  34.1 28.4 20.7  
NTCh  36.4 44.5 33.7 33.7 29.9 
a virus identified by diagnostic RT-PCR 
b virus identified by microarray 
c virus determined by real-time RT-PCR, RV-A (rotavirus group A), HAdV (human adenovirus), HEV (human 
enterovirus), NV (Norwalk virus), HAstV (human astrovirus) 
d NV is detected at genus level as calicivirus 
e Single infection samples were used as positive control 
f Ct value detected by real-time RT-PCR 
g lower Ct values are shown in bold 
h NTC non template control 
 
